Abstract
Regulatory T (Tregs) cells, required to maintain immune homeostasis, have significant power in disease outcomes. Treg dysfunction, predominantly characterized by the loss of the master transcription factor FoxP3 and the acquisition of Teff-like phenotypes, can promote autoimmunity as well as enhance anti-tumor immunity. As FoxP3 expression and stability are pinnacle for Treg suppressive functions, understanding the pathways that regulate FoxP3 is crucial to ascertain Treg-mediated therapies for autoimmune diseases and cancer. Mechanisms controlling FoxP3 expression and stability range from transcriptional to posttranslational, revealing multiple therapeutic opportunities. While many of the transcriptional pathways have been explored in detail, a recent surge in interest on the posttranslational mechanisms regulating FoxP3 has arisen. Particularly, the role of ubiquitination on Tregs both directly and indirectly involving FoxP3 has gained interest. Here, we summarize the current knowledge on ubiquitin-dependent, FoxP3-mediated control of Treg function as it pertains to human diseases.
Deyu Fang is a Lead Contact.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akimova T, Zhang T, Negorev D, Singhal S, Stadanlick J, Rao A, Annunziata M et al (2017) Human lung tumor FOXP+ Tregs upregulate four ‘Treg-locking’ transcription factors. JCI Insight 2(16):e94075
Akiyama T, Maeda S, Yamane S, Ogino K, Kasai M, Kajiura F, Matsumoto M et al (2005) Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 308(5719):248–251
Amano T, Yamasaki S, Yagishita N, Tsuchimochi K, Shin H, Kawahara K, Aratani S et al (2003) Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev 17(19):2436–2449
Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, Seroogy C, Skrenta H et al (2003) GRAIL an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18(4):535–547
Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, Levine MH, Wang Z et al (2017) Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab 25(6):1282–1293.e7
Bachmaier K, Krawczyk C, Kozieradzki I, Kong Y-Y, Sasaki T, Oliveira-dos-Santos A, Mariathasan S et al (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403(6766):211–216
Bai Y, Yang C, Hu K, Elly C, Liu Y-C (2004) Itch E3 ligase-mediated regulation of TGF-β signaling by modulating Smad2 phosphorylation. Mol Cell 15(5):825–831
Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin L-Y, Patterson C (1999) Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19(6):4535–4545
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235–238
BIRAC Consortium, Year Consortium, Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A et al (2009) Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 41(12):1313–1318
Cejas PJ, Walsh MC, Pearce EL, Han D, Harms GM, Artis D, Turka LA et al (2010) TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2. Blood 115(23):4750–4757
Chang J-H, Xiao Y, Hu H, Jin J, Yu J, Zhou X, Wu X et al (2012) Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol 13(5):481–490
Chauhan D, Tian Z, Nicholson B, Kumar KGS, Zhou B, Carrasco R, McDermott JL et al (2012) A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22(3):345–358
Chen Z, Barbi J, Bu S, Yang H-Y, Li Z, Gao Y, Jinasena D et al (2013) The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3. Immunity 39(2):272–285
Chen T, Hou X, Ni Y, Du W, Han H, Yu Y, Shi G (2018) The imbalance of FOXP3/GATA3 in regulatory T cells from the peripheral blood of asthmatic patients. J Immunol Res 2018:1–10
Chernikova SB, Razorenova OV, Higgins JP, Sishc BJ, Nicolau M, Dorth JA, Chernikova DA et al (2012) Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Res 72(8):2111–2119
Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu R-J, Jang IK et al (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403(6766):216–220
Chiffoleau E, Kobayashi T, Walsh MC, King CG, Walsh PT, Hancock WW, Choi Y et al (2003) TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease. J Immunol 171(11):5751–5759
Ciechanover A, Elias S, Heller H, Hershko A (1982) ‘Covalent affinity’ purification of ubiquitin-activating enzyme. J Biol Chem 257(5):2537–2542
Ciehanover A, Hod Y, Hershko A (1978) A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun 81(4):1100–1105
Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH (2007) Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 67(19):9518–9527
Cortez JT, Montauti E, Shifrut E, Gatchalian J, Zhang Y, Shaked O, Xu Y et al (2020) CRISPR screen in regulatory T cells reveals modulators of Foxp3. Nature 582(7812):416–420
Cyr DM, Höhfeld J, Patterson C (2002) Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci 27(7):368–375
Dang EV, Barbi J, Yang H-Y, Jinasena D, Yu H, Zheng Y, Bordman Z et al (2011) Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 146(5):772–784
De Simone M, Arrigoni A, Rossetti G, Gruarin P, Ranzani V, Politano C, Bonnal RJP et al (2016) Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells. Immunity 45(5):1135–1147
DeWan AT, Egan KB, Hellenbrand K, Sorrentino K, Pizzoferrato N, Walsh KM, Bracken MB (2012) Whole-exome sequencing of a pedigree segregating asthma. BMC Med Genet 13(1):95
DonÃz-Padilla L, MartÃnez-Jiménez V, Niño-Moreno P, Abud-Mendoza C, Hernández-Castro B, González-Amaro R, Layseca-Espinosa E et al (2011) Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population. Lupus 20(6):628–635
Egawa S, Iijima H, Shinzaki S, Nakajima S, Wang J, Kondo J, Ishii S et al (2008) Upregulation of GRAIL is associated with remission of ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 295(1):G163–G169
Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang L-P, Gimotty PA et al (2011) Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 475(7355):226–230
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330–336
Fraile JM, Quesada V, RodrÃguez D, Freije JMP, López-OtÃn C (2011) Deubiquitinases in cancer: new functions and therapeutic options. Oncogene 31(19):2373–2388
Fukushima T, Matsuzawa S-i, Kress CL, Bruey JM, Krajewska M, Lefebvre S, Zapata JM et al (2007) Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc Natl Acad Sci 104(15):6371–6376
Gao Y, Tang J, Chen W, Li Q, Nie J, Lin F, Wu Q et al (2015) Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1. Proc Natl Acad Sci 112(25):E3246–E3254
Gerondakis S, Banerjee A, Grigoriadis G, Vasanthakumar A, Gugasyan R, Sidwell T, Grumont RJ (2012) NF-κB subunit specificity in hemopoiesis. Immunol Rev 246(1):272–285
Glinsky GV (2006) Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated PcG protein chromatin silencing pathway. Cell Cycle 5(11):1208–1216
Glinsky GV, Berezovska O, Glinskii AB (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Investig 115(6):1503–1521
Gong L, Kamitani T, Millas S, Yeh ETH (2000) Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem 275(19):14212–14216
Guan S-Y, Leng R-X, Tao J-H, Li X-P, Ye D-Q, Olsen N, Zheng SG, Pan H-F (2017) Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases. Expert Opin Ther Targets 21(7):715–723
Guo Y, Zhao M, Lu Q (2016) Transcription factor RFX1 is ubiquitinated by E3 ligase STUB1 in systemic lupus erythematosus. Clin Immunol 169:1–7
Hahn MA, Dickson K-A, Jackson S, Clarkson A, Gill AJ, Marsh DJ (2012) The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Hum Mol Genet 21(3):559–568
Hanna J, Leggett DS, Finley D (2003) Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol Cell Biol 23(24):9251–9261
Harada Y, Harada Y, Elly C, Ying G, Paik J-H, DePinho RA, Liu Y-C (2010) Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med 207(7):1381–1391
Holtzman MJ, Byers DE, Alexander-Brett J, Wang X (2014) The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat Rev Immunol 14(10):686–698
Horikawa N, Abiko K, Matsumura N, Hamanishi J, Baba T, Yamaguchi K, Yoshioka Y et al (2017) Expression of vascular endothelial growth factor in ovarian cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells. Clin Cancer Res 23(2):587–599
Horwitz DA, Zheng SG, Gray JD (2008) Natural and TGF-β–induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other. Trends Immunol 29(9):429–435
Hsiao H-W, Hsu T-S, Liu W-H, Hsieh W-C, Chou T-F, Wu Y-J, Jiang S-T et al (2015) Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun 6(1):6353
Isomura I, Palmer S, Grumont RJ, Bunting K, Hoyne G, Wilkinson N, Banerjee A et al (2009) c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med 206(13):3001–3014
Ivashkiv LB (2020) The hypoxia–lactate axis tempers inflammation. Nat Rev Immunol 20:85–86
Jiang S, Song C, Gu X, Wang M, Miao D, Lv J, Liu Y (2018) Ubiquitin-specific peptidase 22 contributes to colorectal cancer stemness and chemoresistance via Wnt/β-catenin pathway. Cell Physiol Biochem 46(4):1412–1422
Jin H, Park Y, Elly C, Liu Y-C (2013) Itch expression by Treg cells controls Th2 inflammatory responses. J Clin Investig 123(11):4923–4934
Johnson ES, Ma PCM, Ota IM, Varshavsky A (1995) A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem 270(29):17442–17456
Kerdiles YM, Stone EL, Beisner DL, McGargill MA, Ch’en IL, Stockmann C, Katayama CD et al (2010) Foxo transcription factors control regulatory T cell development and function. Immunity 33(6):890–904
Kim HT, Kim KP, Lledias F, Kisselev AF, Scaglione KM, Skowyra D, Gygi SP et al (2007) Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 282(24):17375–17386
Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M, Sano S et al (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 25(20):4877–4887
Kobayashi T, Walsh PT, Walsh MC, Speirs KM, Chiffoleau E, King CG, Hancock WW et al (2003) TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 19(3):353–363
Kong N, Lan Q, Chen M, Zheng T, Su W, Wang J, Yang Z et al (2012) Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis 71(9):1567–1572
Li L, Osdal T, Ho Y, Chun S, McDonald T, Agarwal P, Lin A et al (2014) SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell 15(4):431–446
Li Y, Lu Y, Wang S, Han Z, Zhu F, Ni Y, Liang R et al (2016) USP21 prevents the generation of T-helper-1-like Treg cells. Nat Commun 7(1):13559
Lin Z, Yang H, Kong Q, Li J, Lee S-M, Gao B, Dong H et al (2012) USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell 46(4):484–494
Lin Z, Tan C, Qiu Q, Kong S, Yang H, Zhao F, Liu Z et al (2015) Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1. Cell Discov 1(1):15028
Liston A, Lu L-F, O’Carroll D, Tarakhovsky A, Rudensky AY (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205(9):1993–2004
Lohr NJ, Molleston JP, Strauss KA, Torres-Martinez W, Sherman EA, Squires RH, Rider NL et al (2010) Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am J Hum Genet 86(3):447–453
Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, Wang J et al (2014) Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci 111(33):E3432–E3440
Lv L, Xiao X, Gu Z, Zeng F, Huang L, Jiang G (2011) Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Mol Cell Biochem 346(1–2):11–21
MacKenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, Seroogy CM (2007) GRAIL is up-regulated in CD4 + CD25 + T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem 282(13):9696–9702
Mahajan D, Wang Y, Qin X, Wang Y, Zheng G, Wang YM, Alexander SI et al (2006) CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 17(10):2731–2741
Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F (2003) CD4+CD25+ TR cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197(1):111–119
Mao F, Kong H, Zhao Y, Peng L, Chen W, Zhang J, Cheng P et al (2017) Increased tumor-infiltrating CD45RA−CCR7− regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress. Cell Death Dis 8(8):e3002–e3002
Martinon F, Chen X, Lee A-H, Glimcher LH (2010) TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 11(5):411–418
Muto G, Kotani H, Kondo T, Morita R, Tsuruta S, Kobayashi T, Luche H et al (2013) TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity. PLoS One 8(9):e74639
Namjou B, Choi C-B, Harley ITW, Alarcón-Riquelme ME, Network B, Kelly JA, Glenn SB et al (2012) Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis Rheum 64(6):1960–1969
Ni X, Kou W, Gu J, Wei P, Wu X, Peng H, Tao J et al (2019) TRAF 6 directs FOXP 3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination. EMBO J 38(9):e99766, available at: https://doi.org/10.15252/embj.201899766
Nicholson B, Kumar KGS (2011) The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys 60(1–2):61
Nurieva RI, Zheng S, Jin W, Chung Y, Zhang Y, Martinez GJ, Reynolds JM et al (2010) The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32(5):670–680
Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J et al (2003) A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 21(8):921–926
Piao S, Liu Y, Hu J, Guo F, Ma J, Sun Y, Zhang B (2012) USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma. PLoS One 7(8):e42540
Plitas G, Konopacki C, Wu K, Bos PD, Morrow M, Putintseva EV, Chudakov DM et al (2016) Regulatory T cells exhibit distinct features in human breast cancer. Immunity 45(5):1122–1134
Prenzel T, Begus-Nahrmann Y, Kramer F, Hennion M, Hsu C, Gorsler T, Hintermair C et al (2011) Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Res 71(17):5739–5753
Rech AJ, Mick R, Martin S, Recio A, Aqui NA, Powell DJ, Colligon TA et al (2012) CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Sci Transl Med 4(134):134ra62
Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E, Bergers G (2015) Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Rep 11(4):577–591
Robb R, Munck A, Smith K (1981) T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med 154(5):1455–1474
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164
Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, Murru R, Whalen MB et al (2010) Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 42(6):495–497
Sawant DV, Yano H, Chikina M, Zhang Q, Liao M, Liu C, Callahan DJ et al (2019) Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion. Nat Immunol 20(6):724–735
Schaer DA, Budhu S, Liu C, Bryson C, Malandro N, Cohen A, Zhong H et al (2013) GITR pathway activation abrogates tumor immune suppression through loss of regulatory T-cell lineage stability. Cancer Immunol Res 1(5):320–331
Schmidt-Supprian M, Tian J, Grant EP, Pasparakis M, Maehr R, Ovaa H, Ploegh HL et al (2004) Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc Natl Acad Sci U S A 101(13):4566–4571
Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N, Raver-Shapira N et al (2008) The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev 22(19):2664–2676
Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H (2011) HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208(7):1367–1376
Shimo Y, Yanai H, Ohshima D, Qin J, Motegi H, Maruyama Y, Hori S et al (2011) TRAF6 directs commitment to regulatory T cells in thymocytes. Genes Cells 16(4):437–447
Singh B, Read S, Asseman C, Malmström V, Mottet C, Stephens LA, Stepankova R et al (2001) Control of intestinal inflammation by regulatory T cells. Immunol Rev 182(1):190–200
Suresh B, Lee J, Kim H, Ramakrishna S (2016) Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ 23(8):1257–1264
Tai X, Cowan M, Feigenbaum L, Singer A (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6(2):152–162
Takahashi R, Nishimoto S, Muto G, Sekiya T, Tamiya T, Kimura A, Morita R et al (2011) SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-γ and IL-17A production. J Exp Med 208(10):2055–2067
Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, Zheng XX et al (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4 + CD25 + regulatory T cells. J Immunol 171(7):3348–3352
Tarcic O, Pateras IS, Cooks T, Shema E, Kanterman J, Ashkenazi H, Boocholez H et al (2016) RNF20 links histone H2B ubiquitylation with inflammation and inflammation-associated cancer. Cell Rep 14(6):1462–1476
Tenno T, Fujiwara K, Tochio H, Iwai K, Morita EH, Hayashi H, Murata S et al (2004) Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells 9(10):865–875
van Loosdregt J, Vercoulen Y, Guichelaar T, Gent YYJ, Beekman JM, van Beekum O, Brenkman AB et al (2009) Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115(5):965–974
van Loosdregt J, Brunen D, Fleskens V, Pals CEGM, Lam EWF, Coffer PJ (2011) Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS One 6(4):e19047
van Loosdregt J, Fleskens V, Fu J, Brenkman AB, Bekker CPJ, Pals CEGM, Meerding J et al (2013) Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. Immunity 39(2):259–271
Venuprasad K, Huang H, Harada Y, Elly C, Subramaniam M, Spelsberg T, Su J et al (2008) The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat Immunol 9(3):245–253
Vignali DAA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523–532
Wang Y, Su MA, Wan YY (2011) An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35(3):337–348
Wang G, Gao Y, Li L, Jin G, Cai Z, Chao J-I, Lin H-K (2012) K63-linked ubiquitination in kinase activation and cancer. Front Oncol 2:5
Wang Z-J, Yang J-L, Wang Y-P, Lou J-Y, Chen J, Liu C, Guo L-D (2013) Decreased histone H2B monoubiquitination in malignant gastric carcinoma. World J Gastroenterol 19(44):8099–8107
Wang L, Kumar S, Dahiya S, Wang F, Wu J, Newick K, Han R et al (2016) Ubiquitin-specific protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity. EBioMedicine 13:99–112
Wei Q, Sha Y, Bhattacharya A, Fattah EA, Bonilla D, Jyothula SSSK, Pandit L et al (2013) Regulation of IL-4 receptor signaling by STUB1 in lung inflammation. Am J Respir Crit Care Med 189(1):16–29
Westendorf AM, Skibbe K, Adamczyk A, Buer J, Geffers R, Hansen W, Pastille E et al (2017) Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting Treg activity. Cell Physiol Biochem 41(4):1271–1284
Wilkinson KD (1997) Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J 11(14):1245–1256
Wohlfert EA, Grainger JR, Bouladoux N, Konkel JE, Oldenhove G, Ribeiro CH, Hall JA et al (2011) GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J Clin Investig 121(11):4503–4515
Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC et al (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61(12):4766–4772
Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, Rush J et al (2009) Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137(1):133–145
Xu Y, Zhao F, Qiu Q, Chen K, Wei J, Kong Q, Gao B et al (2016) The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity. Nat Commun 7(1):12073
Xu Y, Melo-Cardenas J, Zhang Y, Gau I, Wei J, Montauti E, Zhang Y et al (2019) The E3 ligase Hrd1 stabilizes Tregs by antagonizing inflammatory cytokine–induced ER stress response. JCI Insight 4(5):e121887
Yu Y, Su Z, Wang Z, Xu H (2017) USP7 is associated with greater disease activity in systemic lupus erythematosus via stabilization of the IFNα receptor. Mol Med Rep 16(2):2274–2280
Zhang X-Y, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A et al (2008) The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell 29(1):102–111
Zhang J, Chen C, Hou X, Gao Y, Lin F, Yang J, Gao Z et al (2013) Identification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3. J Biol Chem 288(13):9373–9382
Zhang Y, Chen Z, Luo X, Wu B, Li B, Wang B (2016) Cimetidine down-regulates stability of Foxp3 protein via Stub1 in Treg cells. Hum Vaccin Immunother 12(10):2512–2518
Zhao Y, Guo H, Qiao G, Zucker M, Langdon WY, Zhang J (2015) E3 ubiquitin ligase Cbl-b regulates thymic-derived CD4+CD25+ regulatory T cell development by targeting Foxp3 for ubiquitination. J Immunol 194(4):1639–1645
Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA (2002) Generation ex vivo of TGF-β-producing regulatory T cells from CD4+CD25− precursors. J Immunol 169(8):4183–4189
Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J Immunol 172(9):5213–5221
Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA (2006) TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176(6):3321–3329
Zheng SG, Wang J, Horwitz DA (2008) Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6. J Immunol 180(11):7112–7116
Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA (2008) Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205(9):1983–1991
Zhou X, Kong N, Wang J, Fan H, Zou H, Horwitz D, Brand D et al (2010) Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 185(5):2675–2679
Acknowledgments
This study was supported by the NIH grant DK120330 and CA232347 to DF, as well as F31 CA220801-03 to EM.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Montauti, E., Fang, D. (2021). Regulation of Treg Functions by the Ubiquitin Pathway. In: Zheng, SG. (eds) T Regulatory Cells in Human Health and Diseases. Advances in Experimental Medicine and Biology, vol 1278. Springer, Singapore. https://doi.org/10.1007/978-981-15-6407-9_3
Download citation
DOI: https://doi.org/10.1007/978-981-15-6407-9_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6406-2
Online ISBN: 978-981-15-6407-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)